News | Weight-Loss Drugs Raise Concerns About Effects on Menstrual Cycles and Fertility
As weight-loss drugs become increasingly common, their effects on female reproductive health have drawn attention from both the medical community and the public. Some women have recently reported becoming pregnant despite taking oral contraceptives, prompting discussion about whether weight-loss drugs may interfere with contraception. Although there is not yet sufficient evidence that these medications directly reduce contraceptive effectiveness, their potential effects on other aspects of female reproductive health warrant attention.
How Weight-Loss Drugs Work and Their Effects on Menstrual Cycles
Weight-loss drugs such as Mounjaro and Wegovy mainly contain GLP-1 receptor agonists. They promote rapid loss of weight and body fat by regulating certain brain pathways or changing how the body stores energy. However, the resulting changes in metabolism and hormonal balance may cause irregular menstrual cycles and potentially broader reproductive health issues.
These medications can affect the reproductive system because female reproduction requires substantial energy. Rapid loss of weight or body fat may cause menstruation to stop. It is important to monitor menstrual cycle changes while using weight-loss drugs and seek professional medical advice.
Irregular Ovulation and Fertility
Weight-loss drugs create an energy deficit that signals the hypothalamus, the brain’s hormone-regulating center, to suppress the release of gonadotropin-releasing hormone (GnRH). This may cause irregular ovulation or stop it entirely, reducing the likelihood of pregnancy by 30–40%. A reduction in body fat below 17% can also affect estrogen levels, while rapid weight loss creates physical stress that may further suppress reproductive function.
Pregnancy may be delayed in women planning to conceive after weight-loss treatment. Women are advised to stop weight-loss medication at least two months before trying to conceive and to consult a healthcare professional during this period.
Potential Benefits of Weight-Loss Drugs for Polycystic Ovary Syndrome (PCOS)
About one in five women in the United Kingdom is affected by polycystic ovary syndrome (PCOS), a hormonal disorder that can cause insulin resistance, weight gain, and impaired fertility. Research is currently examining whether semaglutide, an active ingredient in weight-loss drugs such as Wegovy, can improve insulin sensitivity and relieve PCOS symptoms.
Studies indicate that semaglutide can improve the body’s response to insulin, lower blood glucose, and reduce insulin resistance. This process supports weight loss and may help regulate hormonal imbalances, easing PCOS-related symptoms. For women hoping to conceive, these treatments may restore regular ovulation and substantially improve the chance of pregnancy.
Although these findings are promising, women are still advised to consult a medical specialist for an individualized treatment plan rather than using these medications on their own.
Weight-Loss Drugs and Changes in Libido
Weight-loss drugs may improve not only weight and physical health but also libido and sexual well-being. Women who feel self-conscious about their weight may experience greater libido and sexual satisfaction as their body image improves during weight loss. Improved hormonal balance after weight loss may also enhance libido, particularly in women with conditions such as PCOS.
However, some weight-loss drugs may initially affect libido or sexual function. Women experiencing these changes should communicate openly and seek medical advice to protect their sexual health.
News | Weight-Loss Drugs Raise Concerns About Effects on Menstrual Cycles and Fertility
News | Weight-Loss Drugs Raise Concerns About Effects on Menstrual Cycles and Fertility
As weight-loss drugs become increasingly common, their effects on female reproductive health have drawn attention from both the medical community and the public. Some women have recently reported becoming pregnant despite taking oral contraceptives, prompting discussion about whether weight-loss drugs may interfere with contraception. Although there is not yet sufficient evidence that these medications directly reduce contraceptive effectiveness, their potential effects on other aspects of female reproductive health warrant attention.
How Weight-Loss Drugs Work and Their Effects on Menstrual Cycles
Weight-loss drugs such as Mounjaro and Wegovy mainly contain GLP-1 receptor agonists. They promote rapid loss of weight and body fat by regulating certain brain pathways or changing how the body stores energy. However, the resulting changes in metabolism and hormonal balance may cause irregular menstrual cycles and potentially broader reproductive health issues.
These medications can affect the reproductive system because female reproduction requires substantial energy. Rapid loss of weight or body fat may cause menstruation to stop. It is important to monitor menstrual cycle changes while using weight-loss drugs and seek professional medical advice.
Irregular Ovulation and Fertility
Weight-loss drugs create an energy deficit that signals the hypothalamus, the brain’s hormone-regulating center, to suppress the release of gonadotropin-releasing hormone (GnRH). This may cause irregular ovulation or stop it entirely, reducing the likelihood of pregnancy by 30–40%. A reduction in body fat below 17% can also affect estrogen levels, while rapid weight loss creates physical stress that may further suppress reproductive function.
Pregnancy may be delayed in women planning to conceive after weight-loss treatment. Women are advised to stop weight-loss medication at least two months before trying to conceive and to consult a healthcare professional during this period.
Potential Benefits of Weight-Loss Drugs for Polycystic Ovary Syndrome (PCOS)
About one in five women in the United Kingdom is affected by polycystic ovary syndrome (PCOS), a hormonal disorder that can cause insulin resistance, weight gain, and impaired fertility. Research is currently examining whether semaglutide, an active ingredient in weight-loss drugs such as Wegovy, can improve insulin sensitivity and relieve PCOS symptoms.
Studies indicate that semaglutide can improve the body’s response to insulin, lower blood glucose, and reduce insulin resistance. This process supports weight loss and may help regulate hormonal imbalances, easing PCOS-related symptoms. For women hoping to conceive, these treatments may restore regular ovulation and substantially improve the chance of pregnancy.
Although these findings are promising, women are still advised to consult a medical specialist for an individualized treatment plan rather than using these medications on their own.
Weight-Loss Drugs and Changes in Libido
Weight-loss drugs may improve not only weight and physical health but also libido and sexual well-being. Women who feel self-conscious about their weight may experience greater libido and sexual satisfaction as their body image improves during weight loss. Improved hormonal balance after weight loss may also enhance libido, particularly in women with conditions such as PCOS.
However, some weight-loss drugs may initially affect libido or sexual function. Women experiencing these changes should communicate openly and seek medical advice to protect their sexual health.
Story source:
Collected online